Molina Healthcare, Inc. (NYSE:MOH) Receives Consensus Rating of “Hold” from Analysts

Molina Healthcare, Inc. (NYSE:MOH) has been given a consensus recommendation of “Hold” by the nine analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $393.09.

MOH has been the subject of a number of research reports. Barclays initiated coverage on shares of Molina Healthcare in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $437.00 price target for the company. Bank of America downgraded shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price target for the company. in a research note on Thursday, March 28th. Truist Financial upped their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the stock a “buy” rating in a report on Tuesday, February 20th. Wells Fargo & Company cut their price objective on shares of Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating on the stock in a report on Monday, April 15th. Finally, StockNews.com cut shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th.

Molina Healthcare Stock Performance

Shares of NYSE:MOH opened at $367.52 on Friday. Molina Healthcare has a 12 month low of $266.35 and a 12 month high of $423.92. The company has a market cap of $21.53 billion, a price-to-earnings ratio of 19.57, a price-to-earnings-growth ratio of 1.01 and a beta of 0.47. The company has a 50-day moving average price of $394.33 and a 200-day moving average price of $370.95. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.57.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.31 by $0.07. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The company had revenue of $9.05 billion during the quarter, compared to the consensus estimate of $8.35 billion. During the same period in the prior year, the firm earned $4.10 earnings per share. Molina Healthcare’s revenue was up 10.0% on a year-over-year basis. As a group, equities analysts anticipate that Molina Healthcare will post 23.62 EPS for the current year.

Insider Activity

In other news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the sale, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The transaction was disclosed in a filing with the SEC, which is available at this link. In related news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the transaction, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the transaction, the director now owns 11,207 shares in the company, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders have sold a total of 16,711 shares of company stock worth $6,472,517 over the last 90 days. 1.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Deutsche Bank AG raised its position in Molina Healthcare by 1.5% in the third quarter. Deutsche Bank AG now owns 258,441 shares of the company’s stock worth $84,740,000 after acquiring an additional 3,754 shares during the period. Invesco Ltd. raised its position in Molina Healthcare by 10.4% in the third quarter. Invesco Ltd. now owns 1,190,161 shares of the company’s stock worth $390,242,000 after acquiring an additional 112,243 shares during the period. Assenagon Asset Management S.A. raised its position in shares of Molina Healthcare by 4,019.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 103,185 shares of the company’s stock valued at $37,282,000 after purchasing an additional 100,680 shares during the period. DNB Asset Management AS raised its position in shares of Molina Healthcare by 20.7% during the 4th quarter. DNB Asset Management AS now owns 42,852 shares of the company’s stock valued at $15,483,000 after purchasing an additional 7,346 shares during the period. Finally, Principal Financial Group Inc. raised its position in shares of Molina Healthcare by 0.5% during the 3rd quarter. Principal Financial Group Inc. now owns 74,056 shares of the company’s stock valued at $24,282,000 after purchasing an additional 376 shares during the period. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.